title: T4 rectal cancer: do we always need an exenteration?
abstract: The management of rectal cancer has changed dramatically over the last few decades. Due to improvements in the multimodality treatment and the introduction of neoadjuvant chemoradiation, previously irresectable tumours can nowadays be cured by extensive multivisceral resections. These highly complex operations are associated with significant morbidity and mortality. Due to optimization of chemoradiotherapy, the introduction of IORT, increasing knowledge of tumour pathology and patterns of recurrence the need for extensive surgery diminishes. The question arises which patients with T4 rectal cancer really need extensive surgery and who can safely be considered for an organ preserving approach.
authors.affiliation: Department of Surgery, Catharina Hospital, Michelangelolaan 2, 5623, EJ, Eindhoven, The Netherlands, Thomas.vermeer@catharinaziekenhuis.nl.
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Vermeer
authors.forename: Miranda
authors.initials: M
authors.lastname: Kusters
authors.forename: Harm J T
authors.initials: HJ
authors.lastname: Rutten
mesh_terms: D059248:Chemoradiotherapy; D006801:Humans; D009367:Neoplasm Staging; D010385:Pelvic Exenteration; D012004:Rectal Neoplasms / Q000473:pathology / Q000628:therapy*; D012007:Rectum / Q000601:surgery